Speaker(s): 

Gretchen Urban, LGC, Department of Genomic Health, Geisinger - has nothing to disclose

Alexander Chang, MD, Co-Director, Center for Kidney Health Research & Associate Professor, Departments of Nephrology and Population Health Sciences, Geisinger Commonwealth School of Medicine - has the following disclosures: Novartis, Boeringer-Ingelheim, and Bayer (research grants)

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1. Summarize recent practices and updates in genetic testing in nephrology 
2. Report on the diagnostic yield for those who pursued genetic testing 
3. Discuss management outcomes after genetic testing was completed 
4. Describe a multidisciplinary approach to variant of uncertain significant 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Candice Laubach, MBA, Christa Martin, PhD, Jennifer Nunamaker, Christian Lynch, MPH, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, and David Rolston, MD, FACP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Timothy Murphy, MD, Alison Mowery, DNP, CRNP

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None